文献速递中毒与环境急症心脑血管急症重症综合管理与镇静镇痛

安非他酮暴露中与不良心血管事件相关的临床和心电图因素

Clinical and electrocardiographic factors associated with adverse cardiovascular events in bupropion exposures.
PubMed 文献 · Clin Toxicol (Phila) · 2023-07-07
一句话结论成人单药安非他酮暴露中,年龄增长、癫痫发作(单次或复杂)、QRS增宽和QTc延长独立关联不良心血管事件,非故意暴露者未发生此类事件。

该回顾性队列研究查询2019至2020年美国国家毒物数据系统,纳入4640例20岁及以上急性或急性-on-慢性单药安非他酮暴露并在医疗机构评估的患者,排除确认未暴露、以戒断为暴露原因、缺乏随访、记录暴露可能不导致效应及数据缺失者。主要终点为不良心血管事件(使用血管升压药、室性心律失常、心肌损伤或心脏骤停),68例(1.47%)发生。多因素logistic回归显示年龄(OR 1.03;95%CI 1.02-1.05)、单次癫痫发作(OR 9.18;95%CI 4.24-19.9)、复杂癫痫发作(OR 38.9;95%CI 19.3-78.1)、QRS增宽(OR 3.01;95%CI 1.62-5.59)和QTc延长(OR 1.76;95%CI 1.00-3.10)独立关联不良心血管事件;非故意暴露者无不良心血管事件。作者结论认为需进一步研究开发安非他酮心脏毒性的筛查工具和治疗。

要点

  • 4640例成人单药安非他酮暴露中68例(1.47%)发生不良心血管事件(使用血管升压药、室性心律失常、心肌损伤或心脏骤停)。
  • 复杂癫痫发作与不良心血管事件关联最强(OR 38.9;95%CI 19.3-78.1),单次癫痫发作OR 9.18(95%CI 4.24-19.9)。
  • QRS增宽(OR 3.01;95%CI 1.62-5.59)和QTc延长(OR 1.76;95%CI 1.00-3.10)独立关联不良心血管事件。
  • 年龄每增加一岁不良心血管事件风险略升(OR 1.03;95%CI 1.02-1.05)。
  • 非故意暴露者中无不良心血管事件发生,故暴露意图未能纳入回归模型。

适用人群与场景

  • 20岁及以上、急性或急性-on-慢性单药安非他酮暴露并在医疗机构评估的患者。
  • 排除:确认未暴露、以戒断为暴露原因、缺乏随访、记录暴露可能不导致效应及数据缺失者。

诊断标准与关键阈值

  • 不良心血管事件定义:使用血管升压药、室性心律失常、心肌损伤或心脏骤停中任意一项。

红旗征与不能漏的情况

  • 癫痫发作(单次或复杂)与不良心血管事件独立关联,复杂癫痫发作OR 38.9(95%CI 19.3-78.1),单次发作OR 9.18(95%CI 4.24-19.9)。
  • QRS增宽(OR 3.01;95%CI 1.62-5.59)和QTc延长(OR 1.76;95%CI 1.00-3.10)独立关联不良心血管事件。

研究设计与关键结果

  • 回顾性队列研究查询美国国家毒物数据系统2019至2020年数据,最终分析4640例,56.7%女性,56.5%疑似自杀意图,68例(1.47%)发生不良心血管事件。
  • 多因素logistic回归:年龄OR 1.03(95%CI 1.02-1.05)、单次癫痫发作OR 9.18(95%CI 4.24-19.9)、复杂癫痫发作OR 38.9(95%CI 19.3-78.1)、QRS增宽OR 3.01(95%CI 1.62-5.59)、QTc延长OR 1.76(95%CI 1.00-3.10)独立关联不良心血管事件。
  • 非故意暴露者中无不良心血管事件发生,暴露意图未能纳入回归模型。
  • 事后亚组分析(故意暴露)中,年龄、单次和复杂癫痫发作及QRS增宽仍独立关联不良心血管事件。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,年龄增长、癫痫发作、QRS增宽和QTc延长与安非他酮暴露的不良心血管事件相关;非故意暴露者未发生不良心血管事件。
  • 作者结论指出需进一步研究开发安非他酮心脏毒性的筛查工具和治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Bupropion toxicity can cause cardiogenic shock, ventricular dysrhythmias, and death. Clinical and electrocardiographic factors associated with adverse cardiovascular events in bupropion toxicity have not been well-studied. This study aimed to identify factors associated with adverse cardiovascular events in adult patients with isolated bupropion exposures.

METHODS: This retrospective cohort study queried the National Poison Data System from 2019 through 2020. We included patients 20 years or older with acute or acute-on-chronic single-agent bupropion exposures evaluated in a healthcare facility. Exclusion criteria were confirmed non-exposure, withdrawal as a reason for exposure, lack of follow-up, documentation that exposure was probably not responsible for the effects, and missing data. The primary outcome was adverse cardiovascular events, defined as the presence of any of the following: vasopressor use, ventricular dysrhythmia, myocardial injury, or cardiac arrest. Independent variables were age, the intentionality of exposure, seizures, tachycardia, QRS widening, and QTc prolongation. Multivariable logistic regression was performed to test for independent associations between independent variables and adverse cardiovascular events.

RESULTS: Of 4,640 patients included in the final analysis (56.7% female, 56.5% suspected suicidal intent), 68 (1.47%) experienced an adverse cardiovascular event. Age (odds ratio 1.03; 95% confidence intervals 1.02-1.05), single seizure (odds ratio 9.18; 95% confidence intervals 4.24-19.9) and complicated seizures (odds ratio 38.9; 95% confidence intervals 19.3-78.1), QRS widening (odds ratio 3.01; 95% confidence intervals 1.62-5.59), and QTc prolongation (odds ratio 1.76; 95% confidence intervals 1.00-3.10) were independently associated with adverse cardiovascular events. No patients with unintentional exposure experienced adverse cardiovascular events, prohibiting intentionality from inclusion in the regression model. In the post hoc subgroup analysis of intentional exposures, age, single and complicated seizures, and QRS widening remained independently associated with adverse cardiovascular events.

CONCLUSIONS: Increasing age, seizures, QRS widening, and QTc prolongation were associated with adverse cardiovascular events in bupropion exposures. Adverse cardiovascular events did not occur in unintentional exposures. Further research is needed to develop screening tools and treatments for bupropion cardiotoxicity.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Simpson M, Troger A, Feng C, et al. Clinical and electrocardiographic factors associated with adverse cardiovascular events in bupropion exposures. Clin Toxicol (Phila). 2023. PMID: 37417311. doi:10.1080/15563650.2023.2227997

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。